Neuropathic Pain: Quality-of-Life Impact, Costs and Cost Effectiveness of Therapy

ISSN： 1170-7690

Source： PharmacoEconomics, Vol.27, Iss.2, 2009-01, pp. : 95-112

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Breast Cancer Management: Quality-of-Life and Cost Considerations

By Radice D. Redaelli A.

PharmacoEconomics, Vol. 21, Iss. 6, 2003-01 ,pp. : 383-396

Adis International

Access to resources Recommend Favorite

Neuropathic pain ups resource use, costs in Spain

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 544, 2008-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite

Drug Treatment of Overactive Bladder: Efficacy, Cost and Quality-of-Life Considerations

By Hashim Hashim Paul Abrams

Drugs, Vol. 64, Iss. 15, 2004-01 ,pp. : 1643-1656

Adis International

Access to resources Recommend Favorite

Economic Aspects of Severe Sepsis: A Review of Intensive Care Unit Costs, Cost of Illness and Cost Effectiveness of Therapy

By Hilmar Burchardi

PharmacoEconomics, Vol. 22, Iss. 12, 2004-01 ,pp. : 793-813

Adis International

Access to resources Recommend Favorite

Estimating `Costs' for Cost-Effectiveness Analysis

By Miners Alec

PharmacoEconomics, Vol. 26, Iss. 9, 2008-01 ,pp. : 745-751

Adis International

Access to resources Recommend Favorite